Aarhus C, Denmark

Josephus Dirk Nieland


 

Average Co-Inventor Count = 1.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Aarhus C, DK (2010)
  • Arthus C, DK (2014)

Company Filing History:


Years Active: 2010-2014

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Josephus Dirk Nieland

Introduction

Josephus Dirk Nieland is a notable inventor based in Aarhus C, Denmark. He has made significant contributions to the field of biomedical research, particularly in the development of therapeutic agents targeting various disorders. With a total of 2 patents, Nieland's work focuses on innovative solutions for complex health issues.

Latest Patents

Nieland's latest patents include groundbreaking inventions aimed at treating and preventing disorders caused by delipidation of neural tissue. One of his notable patents is an inhibitor of carnitin-palmitoyl-transferase-1 (CPT-1), which is designed for use in treating conditions related to neural tissue delipidation. Another significant patent involves TNF antagonists, specifically TNF binding polypeptides based on human tetranectin C-type lectin-like domains (CTLD). These polypeptides exhibit improved binding characteristics and efficacy, making them valuable for pharmaceutical compositions aimed at treating pathologies mediated by TNF, such as rheumatoid arthritis.

Career Highlights

Throughout his career, Nieland has worked with various companies, including Anaphore, Inc. and Meta-iq Aps. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

Nieland has collaborated with several professionals in his field, including Helle Krogh Ottow and Mette Munch. These collaborations have further enhanced his research and development efforts.

Conclusion

Josephus Dirk Nieland's contributions to biomedical innovation are noteworthy, particularly in the development of treatments for complex health issues. His patents reflect a commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…